I have a white blood cell count of 317.7 ×10⁹/L; what should I do?

Immediate Management of Extreme Hyperleukocytosis

You have a life-threatening medical emergency requiring immediate hospitalization and urgent cytoreduction—a WBC of 317.7 × 10⁹/L represents extreme hyperleukocytosis with high risk of leukostasis, respiratory failure, intracranial hemorrhage, and tumor lysis syndrome. 1, 2, 3

Immediate Actions (Within Hours)

Emergency Cytoreduction Protocol

• Start aggressive intravenous hydration immediately at 2.5-3 liters/m²/day to prevent tumor lysis syndrome and maintain renal perfusion 2, 4
• Initiate hydroxyurea 50-60 mg/kg/day immediately without waiting for definitive diagnosis to achieve rapid WBC reduction 1, 2, 4
• Begin tumor lysis syndrome prophylaxis with rasburicase (preferred over allopurinol given the extreme WBC elevation and high tumor burden) 2

Critical Diagnostic Workup (Simultaneous with Treatment)

• Obtain peripheral blood smear immediately to assess for blast cells, which would indicate acute leukemia requiring different management 2, 4
• Draw blood cultures before any antibiotics if infection is suspected, though at this WBC level, acute leukemia is far more likely than infection 2
• Perform bone marrow aspiration and biopsy urgently if blasts are present on peripheral smear to confirm acute leukemia and guide definitive therapy 2, 4
• Order comprehensive metabolic panel including electrolytes, uric acid, LDH, calcium, and phosphorus to monitor for tumor lysis syndrome 2

Risk Stratification Based on WBC Level

Your WBC of 317.7 × 10⁹/L places you at extreme risk:

• WBC >100 × 10⁹/L is considered a medical emergency requiring immediate intervention 1, 2, 3
• At levels >300 × 10⁹/L, the risk of leukostasis with organ-threatening complications (pulmonary infiltrates, cerebral hemorrhage) is markedly elevated 1, 3
• Mortality from hyperleukocytosis-related complications ranges from 5-30% without prompt treatment 3

Management Based on Underlying Diagnosis

If Acute Leukemia is Confirmed (Most Likely)

• Start induction chemotherapy immediately once diagnostic samples are obtained—for non-promyelocytic AML, this means cytarabine and anthracycline ("3+7" regimen) 2, 4
• For acute promyelocytic leukemia (APL), initiate ATRA immediately if suspected based on morphology, even before molecular confirmation, and start chemotherapy without delay given WBC >10 × 10⁹/L 4
• Consider leukapheresis for organ-threatening leukostasis (respiratory distress, altered mental status, visual changes), though this should not delay chemotherapy 2
• Maintain platelet transfusion support to keep platelets >50,000/μL if APL is suspected, as coagulopathy is common 4

If Chronic Myeloproliferative Disorder

• Continue hydroxyurea as primary cytoreductive agent to control proliferative cells and reduce organomegaly 4
• Monitor for hydroxyurea resistance defined as failure to reduce WBC to <10 × 10⁹/L after 3 months at ≥2 g/day 1

Critical Supportive Care Measures

Monitoring Requirements

• Check CBC with differential every 12-24 hours until WBC decreases to <100 × 10⁹/L 2
• Monitor electrolytes, uric acid, LDH, calcium, and phosphorus every 6-12 hours for the first 48-72 hours to detect tumor lysis syndrome 2
• Assess for signs of leukostasis: dyspnea, hypoxemia, confusion, visual changes, priapism 1

Transfusion Management

• Avoid red blood cell transfusions until WBC is reduced as increasing blood viscosity can worsen leukostasis 1
• Transfuse platelets if count ≤10 × 10⁹/L to prevent bleeding complications 2, 4

Infection Prophylaxis

• Consider prophylactic fluoroquinolones given the expected profound neutropenia after chemotherapy 2, 4
• Use posaconazole for antifungal prophylaxis as it is superior to fluconazole in high-risk patients 2, 4

Common Pitfalls to Avoid

• Do not delay hydration and hydroxyurea while waiting for definitive diagnosis—the risk of leukostasis-related death is immediate 2, 4
• Do not perform leukapheresis in suspected APL without extreme caution due to severe hemorrhage risk 4
• Do not use growth factors (G-CSF, GM-CSF) after induction chemotherapy as they confound bone marrow interpretation and should be discontinued at least 7 days before remission assessment 2, 4
• Do not assume infection is the cause at this WBC level—acute leukemia or chronic myeloproliferative disorder is far more likely 5

Expected Timeline

• WBC should decrease by 50% within 24-48 hours with hydroxyurea and hydration 2
• Target WBC <100 × 10⁹/L within 1-2 weeks before proceeding with definitive therapy if chronic disease 2, 4
• If acute leukemia, chemotherapy effects on WBC will be seen within 3-7 days 2

This is a hematologic emergency requiring immediate transfer to a facility with hematology/oncology expertise and intensive care capabilities. 3